Treatment of fungal infections in hematology and oncology - Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of Hematology

Volumn 82, Issue SUPPL. 2, 2003, Pages

  Böhme, Angelika ^a   Ruhnke, Markus ^b   Buchheidt, Dieter ^c   Karthaus, Meinolf ^d   Einsele, Hermann ^e   Guth, Stefan ^f   Heussel, Gudrun ^f   Heussel, Claus Peter ^f   Junghanss, Christian ^g   Kern, Winfried K ^h   Kubin, Thomas ⁱ   Maschmeyer, Georg ^j   Sezer, Orhan ^b   Silling, Gerda ^k   Südhoff, Thomas ^l   Szelényi, Hubert ^m   Ullmann, Andrew J ^f  

^a GOETHE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d EVANGELISCHES KRANKENHAUS   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF MÜNSTER   (Germany)

^l RUHR UNIVERSITY BOCHUM   (Germany)

^m III Med Klin   (Germany)

more..

Author keywords

Antifungals; Cancer; Fungal infections; Mycoses; Neutropenia

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ASTEMIZOLE; CARBAMAZEPINE; CASPOFUNGIN; CISAPRIDE; CYTOKINE; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; NYSTATIN; PHENOBARBITAL; PYRROLE DERIVATIVE; QUINIDINE; RAPAMYCIN; RIFAMPICIN; TERFENADINE; VORICONAZOLE;

CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FUNGAL MENINGITIS; FUNGEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG ASPERGILLOSIS; MEDICAL SOCIETY; MUCORMYCOSIS; MYCOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

HEMATOLOGY; HUMANS; MEDICAL ONCOLOGY; MYCOSES;

EID: 0142094087     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0767-1     Document Type: Review

References (47)

1. Ally R, Schürmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, Hodges M, Troke P, Romero AJ and the Esophageal Candidiasis Study Group (2001) A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis 33:1447-1454
2. Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A (1991) Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior AmB therapy. Am J Med 91:142-150
3. Bernard A, Caillot D, Couaillier JF, Casasnovas O, Guy H, Favre JP (1997) Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 64:1441-1447
4. Ruhnke M, Böhme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R, Glasmacher A, Gümbel H, Heussel CP, Karthaus M, Lambrecht E, Südhoff T, Szelényi H (2003) Diagnosis of invasive fungal infections in hematology and oncology. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0768-0
5. Caillot D, Bassaris H, McGeer A, Arthur C, Prentice HG, Seifert W, de Beule K. (2001) Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. Clin Infect Dis 33: e83-e90
6. Caillot D, Casasnovas O, Bernard A, Couaillier J-F, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139-147
7. Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781-805
8. Denning DW, Ribaud P, Milpied N, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563-571
9. Edwards JE Jr, Bodey GP, Bowden RA, Buechner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, Kohno S, Martino P, Meunier F, Mori T, Pfaller MA, Rex JH, Rogers TR, Rubin RH, Solomkin J, Viscoli C, Walsh TJ, White M (1997) International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 25:43-59
10. Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann AJ, Maschmeyer G, Krüger W, Niederwieser D, Link H, Schmidt CA, Oettle H, Klingebiel T (2003) Infectious complications after allogeneic stem cell transplantation - Epidemiology and interventional therapy strategies. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0772-4
11. Ellis M, Spence D, de Pauw B, Meunier F, Marinus A, Collette L, Sylvester R, Meis J, Boogaerts M, Selleslag D, Krcmery V, von Sinner W, MacDonald P, Doyen C, Vandercam B (1998) An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal AmB for treatment of invasive aspergillosis. Clin Infect Dis 27:1406-1412
12. Fätkenheuer G, Buchheidt D, Cornely OA, Fuhr HG, Karthaus M, Kisro J, Leithäuser M, Salwender H, Südhoff T, Szelényi H, Weissinger F (2003) Central venous catheter (CVC -related infections in neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0769-z
13. Habicht JM, Reichenberger F, Gratwohl A, Zerkowski HR, Tamm M (1999) Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients. Ann Thorac Surg 68:321-325
14. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J-W, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New Engl J Med 347:408-415
15. Herbrecht R, Letscher-Bru V, Bowden RA, Kusne S, Anaissie EJ, Graybill JR, Noskin GA, Oppenheim BA, Andrès E, Pietrelli LA (2001) Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 20:460-466
16. Heussel CP, Kauczor HU, Heussel G, Mildenberger P, Dueber C (1997) Aneurysms complicating inflammatory diseases in immunocompromised hosts: value of contrast-enhanced CT. Eur Radiol 7:316-319
17. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337:15-21
18. Hübel K, Dale DC, Engert A, Liles WC (2001) Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis 183:321-328
19. Karthaus M, Huebner G, Elser C, Geissler RG, Heil G, Ganser A (1998) Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation. Ann Hematol 77:41-45
20. Kish MA (2001) Guide to development of practice guidelines. Clin Infect Dis 32:851-854
21. Kontoyiannis DP, Bodey GP (2002) Invasive aspergillosis in 2002: An update. Eur J Clin Microbiol Infect Dis 21:161-172
22. Leenders ACAP, Daenen S, Jansen RLH, Ho WCJ, Loewenberg B, Wijermans PW, Cornelissen J, Herbrecht R, van der Lelie H, Hoogsteden HC, Verbrugh HA, de Marie S (1998) Liposomal AmB compared with AmB deoxycholate in the treatment of documented and suspected neutropenia-induced invasive fungal infections. Br J Haematol 103:205-212
23. Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, de Marie S (1997). Liposomal AmB (AmBisome) compared with AmB both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11:1463-1471
24. Lin S-J, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358-366
25. Link H, Böhme A, Cornely O, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW (2003) Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0764-4
26. Maertens J, Raad I, Petrikkos G, Selleslag D, Petersen F, Sable C, Kartsonis N, Ngai A, Taylor A, Patterson T, Denning D, Walsh T (2002) Update of the multicenter, noncomparative study of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory (R) or intolerant (I) to other antifungal agents: analysis of 90. Abstracts of the 41th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Sep 27, 30:3269
27. Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients. Ann Hematol 82 (Suppl 2) DOI 10.1007/s00277-003-0765-3
28. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020-2029
29. Neely MN, Ghannoum MA (2000) The exciting future of antifungal therapy. Eur J Clin Microbiol Infect Dis 19:897-914
30. Offner F (1997) Hematopoietic growth factors in cancer patients with invasive fungal infections. Eur J Clin Microbiol Infect Dis 16:56-63
31. Ozer H, Armitage JO, Bennett L, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade III JL, Winn RJ, Wozniak AJ, Somerfield MR for the American Society of Clinical Oncology Growth Factors Expert Panel (2000) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 18:3558-3585
32. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, Cenacchi A, Pacilli L, Fabbiano F, del Favero A (1997) Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br J Haematol 99:331-336
33. Phillips P, de Beule K, Frechette G, Tchamouroff S, Vandercam B, Weitner L, Hoepelman A, Stingl G, Clotet B (1998) A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. Clin Infect Dis 26:1368-1373
34. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC (2000) Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 95:3302-3309
35. Rex JH, Bennett JE, Sugar AM, Pappas PG, van-der-Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD (1994) A randomized trial comparing fluconazole with AmB for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 331:1325-1330
36. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group (2003) A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 36:1221-1228
37. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas G, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662-678
38. Saag MS, Graybill RJ, Larsen RA (2000) Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30:710-771
39. DeShazo RD, Chapin K, Swain RE (1997) Fungal sinusitis. N Engl J Med 337:254-259
40. Sobel JD, Vazquez JA (1999) Fungal infections of the urinary tract. World J Urol 17:410-414
41. Stevens DA, Kann VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA (2000) Practice guidelines for diseases caused by aspergillus. Clin Infect Dis 30:696-709
42. Stevens DA, Lee JY (1997) Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group Criteria. Arch Intern Med 157:1857-1862
43. Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG (1999) In vitro amphotericin B resistance in clinical isolates of aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Micorbiol 37:2343-2345
44. Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE (1994) Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 57:1044-1050
45. Walsh TJ (1998) Primary cutaneous aspergillosis - an emerging infection among immunocompromised patients. Clin Infect Dis 27:453-457
46. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ (1998) AmB lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases. Clin Infect Dis 26:1383-1396
47. Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J (1997) A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis 176:227-232